Detta är en artikel från AFP.

AstraZeneca to use part of Russian Covid vaccine in trials

Telegram från AFP / Omni
11 December 2020, 10.59

Pharmaceutical giant AstraZeneca's Russian branch said Friday it would use part of Russia's homemade Sputnik V vaccine in further clinical trials.

"Today we announce a clinical trial programme to assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University, and Sputnik V, developed by Russian Gamaleya Research institute" AstraZeneca said in a statement published on its website in English and Russian.